Cargando…
Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study
OBJECTIVE: To investigate the systemic and ocular factors that affect the response to intensive aflibercept treatment in diabetic macular edema (DME) in a real-world setting. METHODS: This retrospective cohort study evaluated 30 eyes of 23 patients with DME who underwent intensive intravitreal aflib...
Autores principales: | Han, Ye Eun, Jo, Jaehyuck, Kim, Yoon Jeon, Lee, Junyeop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368507/ https://www.ncbi.nlm.nih.gov/pubmed/37497120 http://dx.doi.org/10.1155/2023/1485059 |
Ejemplares similares
-
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015) -
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022) -
Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020) -
Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)